GL1X · GenesisL1 explorer

Research workbench

Human ERK2 with ERK1/2 inhibitor, AZD0364.

Analyse Human ERK2 with ERK1/2 inhibitor, AZD0364. in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6SLG
Type
protein
Length
337 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1; ERK-tide
EC
2.7.11.24
UniProt
P28482
Ligands
LHZ, SO4
Pockets
5 · best druggability 0.65

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33241% helix, 15% strandP28482
BERK-tideprotein50% helix, 0% strand—

Ligands and binding sites

  • LHZ · (6~{R})-7-[[3,4-bis(fluoranyl)phenyl]methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl) amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13680.650.8042LHZ
2730.440.8118empty
3500.310.7715empty
4550.310.7613empty
5540.280.7419empty

Interfaces

1 interface between chains.

  • A–B · 212 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6SLG · Human ERK2 with ERK1/2 inhibitor, AZD0364. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.